Furthermore, studies utilizing FLCN mutation testing, a genetic marker for BHD syndrome, reported more consistent and slightly higher prevalence rates of pneumothorax compared to those employing other diagnostic criteria. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.